Rektorova I, Megova S, Bares M, Rektor I
First Department of Neurology, Masaryk University, Teaching Hospital sv. Anna, Pekarska 53, 656 91, Brno, Czech Republic.
J Neurol Sci. 2005 Mar 15;229-230:157-61. doi: 10.1016/j.jns.2004.11.021. Epub 2004 Dec 16.
Examine whether one session of high frequency repetitive transcranial magnetic stimulation (rTMS) applied over the left dorsolateral prefrontal cortex (DLPFC) would induce any measurable cognitive changes in patients with cerebrovascular disease and mild cognitive deficits.
Seven patients with cerebrovascular disease and mild executive dysfunction entered the randomised, controlled, blinded study with a crossover design. rTMS was applied either over the left DLPFC (an active stimulation site) or over the left motor cortex (MC; a control stimulation site) in one session. Each patient participated in both stimulation sessions (days 1 and 4) and the order of stimulation sites (DLPFC or MC) was randomised. A short battery of neuropsychological tests was performed by a blinded psychologist prior to and after each rTMS session. Psychomotor speed, executive function, and memory were evaluated.
The only mild but significant stimulation site-specific effect of rTMS was observed in the Stroop interference results (i.e. improvement) after the stimulation of DLPFC but not MC in comparison with the baseline scores (Wilcoxon, Z=-2.03, p=0.04). Patients improved in the digit symbols subtest of the Wechsler adult intelligence scale-revised after both rTMS sessions regardless of the stimulation site (DLPFC or MC; Z=-2.06, p=0.04 and Z=-2.06, p=0.04, respectively). There was no measurable effect of rTMS in any other neuropsychological test.
Our pilot study results showed that one session of the high frequency rTMS applied over the left DLPFC was safe in patients with cerebrovascular disease and mild executive deficits, and may induce measurable positive effects on executive functioning.
研究对左侧背外侧前额叶皮质(DLPFC)进行单次高频重复经颅磁刺激(rTMS)是否会在脑血管疾病和轻度认知缺陷患者中引起任何可测量的认知变化。
7名患有脑血管疾病和轻度执行功能障碍的患者进入了一项采用交叉设计的随机、对照、双盲研究。在一次治疗中,rTMS分别施加于左侧DLPFC(一个活跃刺激部位)或左侧运动皮质(MC;一个对照刺激部位)。每位患者都参与了两次刺激治疗(第1天和第4天),刺激部位(DLPFC或MC)的顺序是随机的。在每次rTMS治疗前后,由一位双盲心理学家进行一组简短的神经心理学测试。评估心理运动速度、执行功能和记忆力。
与基线分数相比,仅在DLPFC而非MC刺激后的Stroop干扰结果中观察到rTMS唯一轻微但显著的刺激部位特异性效应(即改善)(Wilcoxon检验,Z = -2.03,p = 0.04)。无论刺激部位是DLPFC还是MC,在两次rTMS治疗后,患者在韦氏成人智力量表修订版的数字符号子测试中均有改善(分别为Z = -2.06,p = 0.04和Z = -2.06,p = 0.04)。在任何其他神经心理学测试中,rTMS均未产生可测量的效应。
我们的初步研究结果表明,对左侧DLPFC进行单次高频rTMS治疗对脑血管疾病和轻度执行功能缺陷患者是安全的,并且可能对执行功能产生可测量的积极影响。